Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Breast Cancer (Tokyo, Japan)|November 23, 2023
A novel system to provide information via online YouTube videos and an evaluation of current online information about hereditary breast cancerAsumi Iesato, Atsushi Fushimi, Rie Tahara, et al.
Surgical Case Reports|April 2, 2020
Male breast metastasis of ureteral cancer: a case reportYoshitaka Ishikawa, Isao Tabei, Atsushi Fushimi, et al.
Scientific Reports|September 19, 2019
Clinical implications of drug-screening assay for recurrent metastatic hormone receptor-positive, human epidermal receptor 2-negative breast cancer using conditionally reprogrammed cellsRei Mimoto, Satomi Yogosawa, Hiroki Saijo, et al.
Carcinogenesis|October 17, 2021
MUC1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomasZhou Luan, Yoshihiro Morimoto, Atsushi Fushimi, et al.
Surgery Today|October 15, 2018
Prognostic impact of multifocal and multicentric breast cancer versus unifocal breast cancerAtsushi Fushimi, Atsushi Yoshida, Hiroshi Yagata, et al.
Breast Cancer (Tokyo, Japan)|May 21, 2025
Assessing the quality of Japanese online breast cancer treatment information using large language models: a comparison of ChatGPT, Claude, and expert evaluationsAtsushi Fushimi, Mitsuo Terada, Rie Tahara, et al.
International Cancer Conference Journal|March 31, 2025
A case of triple-negative breast cancer with thalassemia manifested by anemia progression during neoadjuvant chemotherapyYoshinobu Fuse, Atsushi Fushimi, Eijirou Nagasaki, et al.
Oncogene|June 24, 2021
MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cellsMasayuki Hagiwara, Atsushi Fushimi, Nami Yamashita, et al.
Communications Biology|October 11, 2023
MUC1-C intersects chronic inflammation with epigenetic reprogramming by regulating the set1a compass complex in cancer progressionAtrayee Bhattacharya, Atsushi Fushimi, Keyi Wang, et al.
Journal for Immunotherapy of Cancer|January 26, 2021
MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancerNami Yamashita, Mark Long, Atsushi Fushimi, et al.
Pageof 5